Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05351255
Other study ID # AEHN-IRB-2022-881
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date July 1, 2022
Est. completion date August 30, 2025

Study information

Verified date August 2023
Source Albert Einstein Healthcare Network
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will determine (1) whether baseline inhibitory activity in the primary motor cortex can predict motor learning ability in individuals with cerebellar degeneration, and (2) whether modulating primary motor cortex activity with non-invasive brain stimulation alters motor learning ability in this population.


Description:

Cerebellar damage causes the disabling movement disorder ataxia, which is characterized by impaired movement coordination affecting all body movements. In the arms, ataxia causes reaching movements with irregular, oscillating, and prolonged trajectory paths. People with cerebellar ataxia (PWCA) are also impaired in an important form of motor learning, called adaptation, which normally keeps movement well calibrated. In prior research, the principal investigator showed that PWCA can learn to correct their reaching movements if they instead employ reinforcement learning (RL). Although many PWCA learned optimally in RL conditions, this prior work found variability across individuals: some learned more than others. While adaptation critically relies on cerebellar integrity, RL depends more heavily on dopaminergic circuitry in the midbrain and excitatory plasticity in M1. Cerebellar damage has been shown to increase intracortical inhibition in M1, which may hamper the plasticity needed for RL. The repetitive TMS protocols of continuous theta burst stimulation (cTBS) and intermittent theta burst stimulation (iTBS) have further been shown to modulate intracortical inhibition: cTBS decreases it, while iTBS increases it. Here, the investigators will systematically test whether increased intracortical inhibition in M1 predicts RL capacity (Aim 1) and whether modulating inhibition in M1 can alter RL capacity in PWCA (Aim 2). 12 PWCA from a degenerative condition will complete 4 experimental sessions over a 6-month period. In session 1, TMS will be used to assess baseline recruitment curves for corticomotor excitability and short-interval intracortical inhibition, and the cortical silent period. PWCA will then complete a standardized clinical rating of their ataxia severity and an established behavioral task that requires learning a reaching skill using the RL paradigm. In sessions 2-4, PWCA will complete 3 additional sessions of the RL task. In each session, PWCA will receive cTBS, iTBS, or sham stimulation to modulate intracortical inhibition in M1 prior to performing the RL task. For Aim 1, the investigators will use multi-level regression to quantify relationships between TMS measures of M1 state and the magnitude and speed of learning in the RL task. For Aim 2, the investigators will use multi-level modeling to quantify differences in the magnitude and speed of learning across stimulation conditions. The investigators hypothesize that increased baseline inhibition in M1 will show a positive association with a lower magnitude and speed of learning in the RL task (Aim 1), and cTBS will improve the magnitude of learning, the speed of learning, or both, in the RL task relative to iTBS or sham stimulation (Aim 2).


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 12
Est. completion date August 30, 2025
Est. primary completion date August 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Diagnosis of cerebellar ataxia from cerebellar degeneration - Normal or corrected-to-normal vision - Normal or corrected-to-normal hearing - Meet safety criteria for receipt of transcranial magnetic stimulation Exclusion Criteria: - Extrapyramidal signs on neurologic examination - History of alcohol or illicit drug abuse - Peripheral sensory loss in the arms - Cognitive or attention deficits that interfere with testing, the capacity to understand and follow task instructions, or the capacity to provide informed consent - Orthopedic injury or pain in the arms

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Transcranial Magnetic Stimulation (TMS)
Aim 2 of the study includes an intervention where participants receive a repetitive TMS protocol called theta burst stimulation (TBS) to study its effect on motor learning behavior.

Locations

Country Name City State
United States Moss Rehabilitation Research Institute Elkins Park Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
Albert Einstein Healthcare Network Medical University of South Carolina

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary International Cooperative Ataxia Rating Scale Total Score The sore out of 100 that results from assessment using the International Cooperative Ataxia Rating Scale (ICARS). The rating scale has a minimum score of 0 and a maximum score of 100. Higher scores indicate more severe impairment. Baseline
Primary International Cooperative Ataxia Rating Scale Limb Coordination Sub-Score The score out of 52 that results from assessment using the Limb Kinetic sub-section of the International Cooperative Ataxia Rating Scale (ICARS). The Limb Kinetic sub-score has a minimum score of 0 and a maximum score of 52. Higher scores indicate more severe impairment. Baseline
Primary Reinforcement Learning Rate The slope of the time series of reach path lengths (determined from digital 3D kinematic data recorded using a motion capture system) over the first 80 trials of the intervention phase of the reinforcement motor learning task. During the intervention, assessed up to 10 days
Primary Total Reinforcement Learning The difference in mean reach path length (determined from digital 3D kinematic data recorded using a motion capture system) between the baseline phase and the end of the intervention phase of the reinforcement motor learning task. During the intervention, assessed up to 10 days
Primary Slope of the Corticomotor Excitability Recruitment Curve The slope of motor evoked potential amplitudes (determined from electromyographic recordings of target muscle activity) between TMS intensities of 120-140% of resting motor threshold. Baseline
Primary Slope of the Short-Interval Intracortical Inhibition (SICI) Recruitment Curve SICI will be computed as the difference in average motor evoked potential amplitude (determined from electromyographic recordings of target muscle activity) between a TMS condition where a single conditioning pulse is applied 3 ms before a single test pulse and a TMS condition where only the test pulse is applied. A range of conditioning pulse TMS intensities will be tested and SICI will be measured for each. The outcome measure comprises the slope of the SICI values over each conditioning pulse intensity. Baseline
Primary Cortical Silent Period Single pulses of TMS will be applied at an intensity of 110% of resting motor threshold while participants tonically activate the target muscle at 20% of their maximum voluntary isometric contraction. 12 repetitions of the protocol will be performed. The outcome measure comprises the average time, in ms, from the end of the motor evoked potential to the reoccurrence of tonic background electromyographic activity. Baseline
See also
  Status Clinical Trial Phase
Recruiting NCT04039048 - Effect of ctDCS During Balance Training on Cerebellar Ataxia N/A
Not yet recruiting NCT04054726 - A Study on Cerebello-Spinal tPCS in Ataxia N/A
Completed NCT02887703 - Augmenting Balance in Individuals With Cerebellar Ataxias N/A
Completed NCT02540655 - Efficacy and Safety Study of Stemchymal® in Polyglutamine Spinocerebellar Ataxia Phase 2
Recruiting NCT01958177 - Clinical Study to Evaluate the Safety and Efficacy BMMNC in Cerebellar Ataxia Phase 1/Phase 2
Recruiting NCT03972202 - The Role of Cerebellum in Speech N/A
Recruiting NCT03341416 - Effects of Deep Brain Stimulation of the Dentate Nucleus on Cerebellar Ataxia N/A
Completed NCT05095870 - Evaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS Neuropathies
Completed NCT04790981 - Effect of Motor Imagery Training on Ataxic Children After Medulloblastoma Resection N/A
Completed NCT02900508 - Virtual Reality-based Training in Cerebellar Ataxia N/A
Active, not recruiting NCT05024240 - Interaction of the Cognitive and Sensory-cognitive Tasks With Postural Stability in Individuals With Stability Disorders N/A
Completed NCT00006492 - Gluten-Free Diet in Patients With Gluten Sensitivity and Cerebellar Ataxia N/A
Completed NCT01649687 - Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells Phase 1/Phase 2
Completed NCT04750850 - Core Stability Exercises and Hereditary Ataxia N/A
Active, not recruiting NCT05157802 - Promoting Physical Activity Engagement for People With Early-stage Cerebellar Ataxia Phase 1
Completed NCT05278091 - Evaluation of the Diagnostic Value of Video-oculography in CANVAS Neuronopathies
Completed NCT05436262 - Using Real-time fMRI Neurofeedback and Motor Imagery to Enhance Motor Timing and Precision in Cerebellar Ataxia N/A
Active, not recruiting NCT06152133 - Telerehabilitation, Core Stability Exercises and Hereditary Ataxia (TRCore-ataxia) N/A
Completed NCT04648501 - Dual Task Training for Cerebellar Ataxia N/A
Enrolling by invitation NCT03269201 - Brain Network Activation in Patients With Movement Disorders